Exelixis
EXEL
#1697
Rank
NZ$16.88 B
Marketcap
$59.13
Share price
0.38%
Change (1 day)
70.62%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Cost to borrow shares

Latest borrow fee for Exelixis (EXEL) shares on Interactive Brokers: 0.4050% (annualized)

Shares available to borrow: 9900000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Exelixis (EXEL) - cost to borrow in the last 7 days chart

Exelixis (EXEL) - number of shares available to borrow in the last 7 days

Exelixis (EXEL) - cost to borrow from 2024 to 2023

Exelixis (EXEL) - number of shares available to borrow from 2024 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
0.4224%1.2 M๐Ÿ‡ฌ๐Ÿ‡ง UK
0.4081%2.2 M๐Ÿ‡ซ๐Ÿ‡ท France
0.3048%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.3865%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.2923%4.2 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.25%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.3865%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
3.7542%0.7 M๐Ÿ‡บ๐Ÿ‡ธ USA